Combating the threat of anthrax: a quantitative structure-activity relationship approach

Area of Science:

• Medicinal Chemistry
• Computational Biology
• Infectious Diseases

Background:

• Bacillus anthracis causes anthrax, a high-mortality infectious disease with potential bioweapon applications.
• Effective adjunctive therapies and prevention strategies are crucial for combating anthrax.
• Understanding chemical-biological interactions is vital for developing novel therapeutics.

Purpose of the Study:

• To develop quantitative structure-activity relationship (QSAR) models for penicillin-based inhibitors.
• To investigate inhibitors targeting class A and B beta-lactamases from Bacillus anthracis.
• To analyze inhibitors of the anthrax lethal factor and understand chemical-biological interactions.

Main Methods:

• Development of seven QSAR models.
• Inclusion of penicillin-based inhibitors targeting beta-lactamases and anthrax lethal factor.
• Internal validation (cross-validation, Q-factor, Fischer statistics, Y-randomization) and external validation.

Main Results:

• QSAR models were successfully developed for beta-lactamase and lethal factor inhibitors.
• Hydrophobic and steric factors were identified as the most significant determinants of inhibitory activity.
• All developed QSAR models demonstrated robust validation through internal and external testing.

Conclusions:

• The QSAR models provide valuable insights into the chemical features governing inhibitor efficacy against Bacillus anthracis targets.
• Hydrophobic and steric properties are critical for designing potent inhibitors.
• These findings can guide the rational design of novel therapeutic agents for anthrax treatment and prevention.